A survey of regular ecstasy users' knowledge and practices around determining pill content and purity: Implications for policy and practice

International Journal of Drug Policy

Volumn 17, Issue 6, 2006, Pages 464-472

  Johnston, Jennifer ^a   Barratt, Monica J ^b   Fry, Craig L ^a,c   Kinner, Stuart ^d   Stoové, Mark ^a   Degenhardt, Louisa ^e   George, Jessica ^b   Jenkinson, Rebecca ^a   Dunn, Matthew ^e   Bruno, Raimondo ^f  

^a TURNING POINT ALCOHOL AND DRUG CENTRE   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Content; Ecstasy; Harm reduction; Pill testing; Purity

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; KETAMINE; REAGENT;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; CHEMICAL ANALYSIS; CHI SQUARE TEST; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FRIEND; HUMAN; INFORMATION PROCESSING; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PILL; POLICY; PRIORITY JOURNAL; PURIFICATION; SAMPLE; SUBSTANCE ABUSE;

EID: 33751242775     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2006.03.008     Document Type: Article

References (43)

1. Abraham M., Kaal H., and Cohen P. Licit and illicit drug use in The Netherlands (2001), CEDRO/Mets en Schilt, Amsterdam
2. Australian Institute of Health and Welfare. 2004 National Drug Strategy Household Survey (First results) (2005), Australian Institute of Health and Welfare, Canberra
3. Beck F., Iegleye S., and Peretti-Watel P. Survey EROPP (2002), OFDT, Paris
4. Benschop A., Rabes M., and Korf D.J. Pill testing, ecstasy and prevention. A scientific evaluation in three European cities (2002), Rozenberg Publishers, Amsterdam
5. Biernacki P., and Waldorf D. Snowball sampling: Problems and techniques of chain referral sampling. Sociological Methods & Research 10 (1981) 141-163
6. Breen, C., Degenhardt, L., White, B., Bruno, R., Chanteloup, F., Fischer, J., et al. (2004). Australia Party Drug Trends 2003: Findings from the Party Drugs Initiative (NDARC Monograph No. 52). Sydney: National Drug and Alcohol Research Centre.
7. Caldicott, D. (2005). Personal Communication.
8. Caldicott D., Edwards N.A., Kruys A., Kirkbride K.P., Sims D.N., Byard R.W., et al. Dancing with "Death": P-methoxyamphetamine overdose and its acute management. Journal of Toxicology Clinical Toxicology 41 2 (2003) 143-154
9. Camilleri A.M., and Caldicott D. Underground pill testing, down under. Forensic Science International 151 1 (2005) 53-58
10. Cole J.C., Bailey M., Sumnall H.R., Wagstaff G.F., and King L.A. The content of ecstasy tablets: Implications for the study of their long-term effects. Addiction 97 12 (2002) 1531-1536
11. Condon J., and Smith N. Prevalence of drug use: Key findings from the 2002/2003 British Crime Survey (Statistical Bulletin No. 229) (2003), Home Office, London
12. Dalgarno P.J., and Shewan D. Illicit use of ketamine in Scotland. Journal of Psychoactive Drugs 28 (1996) 191-199
13. Davidson, J. (2005a, September 30). "If the government won't pay..." Peer-initiated harm reduction in the club drugs world. Paper presented at the Club Health 2005, First Australian National Conference on Nightlife, Substance Use and Related Health Issues, Sydney, Australia.
14. Davidson, J. (2005b). Personal Communication.
15. Degenhardt L., Barker B., and Topp L. Patterns of ecstasy use in Australia: Findings from a national household survey. Addiction 99 (2004) 187-195
16. Drugs and Crime Prevention Committee (2004). Inquiry into amphetamine and "party drug" use in Victoria - Final report. Melbourne: DCPC, Parliament of Victoria.
17. Dundes L. DanceSafe and ecstasy: Protection or promotion?. Journal of Health and Social Policy 17 (2003) 19-37
18. EMCDDA. (2001). On-site pill-testing interventions in the European Union. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.
19. Enlighten. Testing kits. Retrieved December 13, 2005, from http://www.enlighten-hr.org/testingkits.php.
20. Forsyth A.J.M. Places and patterns of drug use in the Scottish dance scene. Addiction 91 (1996) 511-521
21. Hayner G.N. MDMA misrepresentation: An unresolved problem for ecstasy users. Journal of Psychoactive Drugs 34 (2002) 195-198
22. Kalasinsky K.S., Hugel J., and Kish S.J. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA). Journal of Forensic Science 49 (2004) 1106-1112
23. Kinner, S., Fowler, G., Fischer, J., Stafford, J., & Degenhardt, L. (2005). Monitoring the ecstasy market in Australia - Challenges and successes (Party Drug Trends Bulletin). Sydney: National Drug and Alcohol Research Centre.
24. Loxley, W., Toumbourou, J. W., Stockwell, T., Haines, B., Scott, K., Godfrey, G., et al. (2004). The prevention of substance use, risk and harm in Australia: A review of the evidence. Canberra: Australian Government Department of Health and Ageing.
25. Murray R.A., Doering P.L., Boothby L.A., Merves M.L., McCusker R.R., Chronister C.W., et al. Putting an ecstasy test kit to the test: Harm reduction or harm induction?. Pharmacotherapy 23 10 (2003) 1238-1244
26. Niesink, R., Nikken, G., Jansen, F., & Spruit, I. P. The drug information and monitoring service (DIMS) in The Netherlands: A unique tool for monitoring party drugs. Retrieved September 14, 2005, from http://www.drugtext.org/library/articles/niesink.htm.
27. Ovenden C., and Loxley W. Bingeing on psychostimulants in Australia: Do we know what it means (and does it matter)?. Addiction Research 4 1 (1996) 33-43
28. Parrott A.C. Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacology 173 (2004) 234-241
29. Quinn C., Breen C., and White B. Illicit Tablet Market in Victoria (Party Drug Trends Bulletin) (2004), National Drug and Alcohol Centre, Sydney
30. Schroers A. Drug checking: Monitoring the contents of new synthetic drugs. Journal of Drug Issues 32 2 (2002) 635-646
31. Shand F., Topp L., Darke S., Makkai T., and Griffiths P. The monitoring of drug trends in Australia. Drug and Alcohol Review 22 (2003) 61-72
32. Spruit I.P. Monitoring synthetic drug markets, trends, and public health. Substance Use and Misuse 36 1-2 (2001) 23-47
33. SPSS Inc. SPSS for Windows (Version 11.0 ed) (2001), SPSS Inc, Chicago
34. Stafford, J., Degenhardt, L., Agaliotis, M., Chanteloup, F., Fischer, J., Matthews, A., et al. (2005). Australian trends in ecstasy and related drug markets 2004: Findings from the Party Drugs Initiative (PDI) (NDARC Monograph No. 57). Sydney: National Drug and Alcohol Research Centre.
35. Substance Abuse and Mental Health Services Administration. (2003). Results from the 2002 National Survey on Drug Use and Health: National Findings. (Series H-22, DHHS Publication No. SMA 03-3836.). Rockville, MD: Office of Applied Studies, NHSDA.
36. Topp L., Barker B., and Degenhardt L. The external validity of results derived from ecstasy users recruited using purposive sampling strategies. Drug and Alcohol Dependence 73 (2004) 33-40
37. Topp L., and Churchill A. Australia's dynamic methamphetamine markets (Illicit Drug Reporting System: Drug Trends Bulletin) (2002), National Drug and Alcohol Research Centre, Sydney
38. Umeh K., and Patel R. Theory of planned behaviour and ecstasy use: An analysis of moderator-interactions. British Journal of Health Psychology 9 1 (2004) 25-38
39. van de Wijngaart G.F., Braam R., de Bruin D., Fris M., Maalste N.J.M., and Verbraeck H.T. Ecstasy use at large-scale dance events in The Netherlands. Journal of Drug Issues 29 3 (1999) 679-702
40. Verheyden S.L., Henry J.A., and Curran H.V. Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users. Human Psychopharmacology: Clinical and Experimental 18 7 (2003) 507-517
41. Webb, T. (2002). Ecstasy and the law: The past, present and future of MDMA's legal regulation in the Australian Capital Territory. Unpublished Bachelor of Law (Honours), The Australian National University, Canberra.
42. White B., Degenhardt L., Breen C., Bruno R., Newman J., and Proudfoot P. Risk and benefit perceptions of party drug use. Addictive Behaviors 31 (2005) 137-142
43. Winstock A.R., Wolff K., and Ramsey J. Ecstasy pill testing: Harm minimization gone too far?. Addiction 96 8 (2001) 1139-1148